U.S. federal trademark · Serial No. 97382032
Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; miniature long-term drug implants utilizing proprietary implantable drug delivery technology
Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy
International Class 001: Nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes in chemical form used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant; nanoporous membranes in chemical form used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases, namely, metabolic diseases being diabetes, obesity or non- alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy; nanoporous membranes in chemical form used for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, · obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases being diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases being Alzheimer's, dementia, sociopathy or psychopathy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.